QuadVantage Aims To Make ACL Reconstruction Surgeries Cost-Effective, Stronger and Less Painful With Patented Autograft System

As people everywhere embrace more active lifestyles, anterior cruciate ligaments (ACL) injuries have continued to increase. In the United States alone, there are between 100,000 and 200,000 ACL ruptures per year. Globally, the ACL reconstruction procedures market is projected to mature from a revenue of $6.8 billion in 2020 and reach $11.5 billion by 2031.

The ACL is one of two crucial ligaments for stabilizing the knee. Tears or sprains in that ligament typically happen during sports or exercise, especially in activities that involve a lot of sudden stops, pivots or jumps, such as soccer, football and basketball.

When torn or sprained, the affected leg becomes unstable, and it can be painful to stand or walk. Active women experience a higher incidence of ACL injuries than men because their biomechanics tend to put more stress on their knees.

While surgical reconstruction is an option, only about half of patients opt for surgery. Surgery is often required to replace the injured ACL. 

Mainstream ACL reconstruction techniques utilize Patellar, Hamstring or Allograft (cadaver) tendon grafts as replacements for the injured tendon. These procedures are painful, prone to failure in some cases, can leave significant scars and can create new ongoing issues. Key issues continue to plague patients that undergo these surgeries. QuadVantage Advanced Medical Devices has developed and patented minimally invasive methods and precision instrumentation that address these issues.

What The QuadVantage System Does Differently

Based on QuadVantage’s research conducted over several decades, it is believed that the Quadriceps tendon is superior to Patellar, Hamstring and Allograft alternatives with respect to tensile properties, size, strength, failure risk and regeneration.

The Quadvantage patented and clinically tested Quadriceps ACL Reconstruction System aims to enable surgeons to deliver a less painful, stronger, less likely to fail, cosmetically superior and cost-effective Quadriceps ACL reconstruction result.

For surgeons, the system makes the Quadriceps tendon accessible and eliminates a lot of the guesswork that makes proper ACL reconstruction challenging. With a complete set of precision tools to aid surgeons in measuring, shaping, harvesting and extracting the quadriceps graft, QuadVantage’s system aims to make it easy for doctors to construct a custom graft for patients, at any age, that will deliver superior results over time.

Later, the company hopes to add fixation devices to the set to make positioning the extracted graft easier and more precise. Already in the early stages of development, QuadVantage says those fixation devices could hit the market by 2024. 

Featured photo provided by Terry Shultz P.T. on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.